Zivo Bioscience, Inc. (ZIVO) › Shareholders' EquityZivo Bioscience, Inc. (ZIVO) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2010: -$951.7K2011: -$2.03M2012: -$3.96M2013: -$9.59M2014: -$6.37M2015: -$9.50M2016: -$13.62M2017: -$16.30M2018: -$22.28M2019: -$8.34M2020: -$11.31M2021: $6.04M2022: -$10.6K2023: -$2.21M2024: -$514.9K-$514.9K2010Shareholders' Equity (USD)2024Fiscal YearShareholders' EquityChange YoY2024-$514.9K+76.7%2023-$2.21M-20666.7%2022-$10.6K-100.2%2021$6.04M+153.4%2020-$11.31M-35.6%2019-$8.34M+62.6%2018-$22.28M-36.7%2017-$16.30M-19.7%2016-$13.62M-43.4%2015-$9.50M-49.1%2014-$6.37M+33.6%2013-$9.59M-142.5%2012-$3.96M-94.7%2011-$2.03M-113.5%2010-$951.7K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share